Your browser doesn't support javascript.
loading
Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases.
Lazaratos, Anna-Maria; Maritan, Sarah M; Quaiattini, Andrea; Darlix, Amelie; Ratosa, Ivica; Ferraro, Emanuela; Griguolo, Gaia; Guarneri, Valentina; Pellerino, Alessia; Hofer, Silvia; Jacot, William; Stemmler, Hans-Joachim; van den Broek, Marcel P H; Dobnikar, Nika; Panet, Francois; Lahijanian, Zubin; Morikawa, Aki; Seidman, Andrew D; Soffietti, Riccardo; Panasci, Lawrence; Petrecca, Kevin; Rose, April A N; Bouganim, Nathaniel; Dankner, Matthew.
Afiliação
  • Lazaratos AM; Rosalind and Morris Goodman Cancer Institute, Montreal, Quebec, Canada; Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.
  • Maritan SM; Rosalind and Morris Goodman Cancer Institute, Montreal, Quebec, Canada; Faculty of Medicine, Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
  • Quaiattini A; Schulich Library of Physical Sciences, Life Sciences, and Engineering, McGill University, Montreal, Quebec, Canada.
  • Darlix A; Department of Medical Oncology, Institut régional du Cancer de Montpellier, University of Montpellier, Montpellier, France; Institut de Génomique Fonctionnelle, INSERM, CNRS, University of Montpellier, Montpellier, France.
  • Ratosa I; Division of Radiotherapy, Institute of Oncology Ljubljana, Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Ferraro E; Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NewYork, USA.
  • Griguolo G; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
  • Guarneri V; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
  • Pellerino A; Division of Neuro-Oncology, Department of Neuroscience, University and City of Health and Science Hospital, Turin, Italy.
  • Hofer S; Department of Neurology, University Hospital Zurich, Switzerland.
  • Jacot W; Department of Medical Oncology, Institut régional du Cancer de Montpellier, University of Montpellier, Montpellier, France.
  • Stemmler HJ; Medical Dept. III, Ludwig Maximilians University Munich, Munchen, Germany.
  • van den Broek MPH; Clinical Pharmacy, Sint Antonius Hospital, Nieuwegein, the Netherlands.
  • Dobnikar N; Division of Radiotherapy, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
  • Panet F; Gerald Bronfman Department of Oncology, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.
  • Lahijanian Z; Department of Diagnostic Radiology, McGill University, Montreal, Quebec, Canada.
  • Morikawa A; Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NewYork, USA.
  • Seidman AD; Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NewYork, USA.
  • Soffietti R; Division of Neuro-Oncology, Department of Neuroscience, University and City of Health and Science Hospital, Turin, Italy.
  • Panasci L; Gerald Bronfman Department of Oncology, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.
  • Petrecca K; Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
  • Rose AAN; Gerald Bronfman Department of Oncology, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada; Lady Davis Institute, Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
  • Bouganim N; Gerald Bronfman Department of Oncology, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada; McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
  • Dankner M; Rosalind and Morris Goodman Cancer Institute, Montreal, Quebec, Canada; Faculty of Medicine, Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada. Electronic address: matthew.dankner@mail.mcgill.ca.
Breast ; 69: 451-468, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37156650
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Trastuzumab / Neoplasias Meníngeas Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: Breast Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Trastuzumab / Neoplasias Meníngeas Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: Breast Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá